| SOXS 1.8066 0.93% | TPET 1.13 169.05% | ONDS 10.67 5.85% | NVDA 182.65 3.08% | STAK 0.7343 72.78% | TMDE 2.51 172.18% | BITO 9.4901 4.75% | TURB 1.24 83.59% | XLE 56.945 1.83% | DUST 3.635 2.68% | TZA 6.055 -2.81% | NOK 8.335 7.97% | NVD 7.07 -6.11% | RYDE 0.3315 43.26% | EONR 0.495 14.58% | BHAT 0.038 -23.23% | IBIT 39.03 4.95% | F 13.325 -5.43% | TQQQ 50.02 1.01% | SLV 80.98 -4.72% | MSTX 2.495 10.89% | PLUG 1.8083 1.02% | USEG 1.16 8.41% | TSLS 5.63 -0.18% | SOXL 62.305 -0.74% | AAL 12.505 -4.32% | AES 14.3188 -17.14% | JDST 1.2001 3.46% | BATL 11.73 112.50% | PLTR 146.0701 6.47% | HYG 80.375 -0.43% | NFLX 97.3 1.10% | QQQ 609.43 0.35% | SPY 687.9525 0.29% | SQQQ 70.125 -1.02% | MARA 9.61 7.49% | SOFI 18.135 2.11% | TSLL 14.705 0.03% | ETHA 15.37 5.85% | XLF 51.5345 0.20% | INTC 45.205 -0.89% | NU 15.309 2.20% | IWM 263.78 0.91% | TSLA 402.69 0.04% | TLT 89.4664 -1.49% | BMNR 20.43 7.64% | CRCG 3.0644 27.68% | NIO 4.7 -3.49% | BYND 0.8496 -10.15% | RIG 6.205 -4.24%

Truist Raises Veeva Systems Price Target But Keeps Hold Rating Ahead Of Q2 Results

Truist Securities raised its price target on Veeva Systems Inc. (NYSE:VEEV) to $268 from $230 while maintaining a Hold rating, ahead of the company’s fiscal second-quarter results scheduled for August 27.

The brokerage said it expects results to come in broadly in line or slightly better, supported by positive commentary from peers DOCS and IQV on end-market demand and spending in pharma tech and analytics.

Truist noted that Veeva shares have risen around 20% since the fiscal first-quarter report, compared with an 8% gain in the S&P 500, suggesting investor expectations already price in a “beat and raise” outcome.

The analysts added that while the mix of a Q2 beat could be important, they expect management to maintain its view for the second half, guiding largely in line with the Q2 performance rather than providing a significant upward revision.

Published on: August 21, 2025